Follow
Konstantinos A. Polyzos
Konstantinos A. Polyzos
MD, MSc, PhD, Karolinska Institutet
Verified email at ki.se
Title
Cited by
Cited by
Year
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis
KA Polyzos, AA Konstantelias, ME Falagas
Ep Europace 17 (5), 767-777, 2015
4682015
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence
KZ Vardakas, KA Polyzos, K Patouni, PI Rafailidis, G Samonis, ...
International journal of antimicrobial agents 40 (1), 1-8, 2012
3042012
Do psychological variables affect early surgical recovery?
MN Mavros, S Athanasiou, ID Gkegkes, KA Polyzos, G Peppas, ...
PloS one 6 (5), e20306, 2011
2552011
Antimicrobial-impregnated and-coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis
AA Konstantelias, KZ Vardakas, KA Polyzos, GS Tansarli, ME Falagas
Journal of neurosurgery 122 (5), 1096-1112, 2015
1142015
The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease
KA Polyzos, DFJ Ketelhuth
Hämostaseologie 35 (02), 128-136, 2015
972015
Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe−/− mice
KA Polyzos, O Ovchinnikova, M Berg, R Baumgartner, H Agardh, J Pirault, ...
Cardiovascular research 106 (2), 295-302, 2015
882015
Maternal influenza vaccination and risk for congenital malformations: a systematic review and meta-analysis
KA Polyzos, AA Konstantelias, CE Pitsa, ME Falagas
Obstetrics & Gynecology 126 (5), 1075-1084, 2015
772015
Hypercholesterolemia induces differentiation of regulatory T cells in the liver
RKW Mailer, A Gisterå, KA Polyzos, DFJ Ketelhuth, GK Hansson
Circulation research 120 (11), 1740-1753, 2017
692017
Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis
KA Polyzos, MN Mavros, KZ Vardakas, MC Makris, PI Rafailidis, ...
Public Library of Science 7 (8), e41870, 2012
682012
Treatment options for 2009 H1N1 influenza: evaluation of the published evidence
ME Falagas, EK Vouloumanou, E Baskouta, PI Rafailidis, K Polyzos, ...
International journal of antimicrobial agents 35 (5), 421-430, 2010
652010
Hypercholesterolemia enhances T cell receptor signaling and increases the regulatory T cell population
RKW Mailer, A Gisterå, KA Polyzos, DFJ Ketelhuth, GK Hansson
Scientific reports 7 (1), 15655, 2017
642017
Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review
MC Makris, KA Polyzos, MN Mavros, S Athanasiou, PI Rafailidis, ...
Drug safety 35, 1-14, 2012
582012
Low-density lipoprotein-reactive T cells regulate plasma cholesterol levels and development of atherosclerosis in humanized hypercholesterolemic mice
A Gisterå, ML Klement, KA Polyzos, RKW Mailer, A Duhlin, MCI Karlsson, ...
Circulation 138 (22), 2513-2526, 2018
522018
Cytomegalovirus restructures lipid rafts via a US28/CDC42-mediated pathway, enhancing cholesterol efflux from host cells
H Low, N Mukhamedova, HL Cui, BP McSharry, S Avdic, A Hoang, ...
Cell reports 16 (1), 186-200, 2016
502016
Acute loss of apolipoprotein E triggers an autoimmune response that accelerates atherosclerosis
M Centa, KE Prokopec, MG Garimella, K Habir, L Hofste, JM Stark, ...
Arteriosclerosis, thrombosis, and vascular biology 38 (8), e145-e158, 2018
472018
Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis
MN Mavros, KA Polyzos, PI Rafailidis, ME Falagas
Journal of Antimicrobial Chemotherapy 66 (2), 251-259, 2011
442011
Activation of the regulatory T-cell/indoleamine 2, 3-dioxygenase axis reduces vascular inflammation and atherosclerosis in hyperlipidemic mice
MJ Forteza, KA Polyzos, R Baumgartner, BE Suur, M Mussbacher, ...
Frontiers in immunology 9, 950, 2018
372018
3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr−/− mice
M Berg, KA Polyzos, H Agardh, R Baumgartner, MJ Forteza, I Kareinen, ...
Cardiovascular research 116 (12), 1948-1957, 2020
362020
Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections
PI Rafailidis, KA Polyzos, K Sgouros, ME Falagas
International journal of antimicrobial agents 37 (4), 283-290, 2011
222011
The inflammatory cytokine interferon‐gamma inhibits sortilin‐1 expression in hepatocytes via the JAK/STAT pathway
J Pirault, KA Polyzos, MH Petri, DFJ Ketelhuth, M Bäck, GK Hansson
European Journal of Immunology 47 (11), 1918-1924, 2017
202017
The system can't perform the operation now. Try again later.
Articles 1–20